Hyperfibrinolysis Detection During Liver Transplantation Using Viscoelastometry
Clinical Transplantation · 2025
DOI: 10.1111/ctr.70179 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Clinical Transplantation, 2025. Verfasst von Sarah Thaler und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology, LMU University Hospital, LMU Munich, Munich, Germany. Hauptthemen laut MEDLINE: Liver Transplantation, Thrombelastography, Fibrinolysis, Blood Coagulation Disorders. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
End‐stage liver disease induces a precarious hemostatic equilibrium, named rebalanced hemostasis. Liver transplantation additionally causes profound disturbances in the hemostatic balance. Hyperfibrinolysis poses a relevant impairment to the coagulation process during liver transplantation. During surgery, the hemostatic management is guided by viscoelastic monitoring systems. The aim of this prospective, observational study was to evaluate the incidence of hyperfibrinolysis during liver transplantation using different viscoelastic assays, namely an ecarin‐based test and a tissue factor‐based test.
Methods
Blood sampling was done at five measurement time points during liver transplantation (T1 induction of general anesthesia, T2 start of anhepatic phase, T3 end of anhepatic phase, T4 10 min after reperfusion, T5 end of surgery). Viscoelastic testing included ClotPro assays EX‐test, FIB‐test, AP‐test, and ECA‐test. Hyperfibrinolysis was defined as a maximum lysis of at least 15%. Lysis detection time (LDT) served as an indicator for the velocity of lysis, marking the time point when less than 85% of the clot are extant.
Results
Thirty transplantation surgeries were included. A total of 150 viscoelastic measurements have been performed. The ECA‐test detected hyperfibrinolysis significantly more often (31 [21%] vs. 22 [15%] out of 150, p = 0.039) and in a higher number of patients than the EX‐test. The ECA‐test revealed hyperfibrinolysis significantly earlier compared to the EX‐test (median LDT 2100 s [1500/2900] vs. 3300 s [2400/3800], p < 0.001).
Conclusion
This study demonstrates higher sensitivity of the ecarin‐test than the tissue‐factor‐test in monitoring hyperfibrinolysis, with more frequent and earlier detection of this coagulopathy. Trial Registration German Clinical Trials Register: DRKS00032827
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anaesthesiology, LMU University Hospital, LMU Munich, Munich, Germany.
- Department of General-, Visceral- and Transplant-Surgery, LMU University Hospital, LMU Munich, Munich, Germany.
ORCID-Profile: Sarah Thaler, Philipp Groene
Zitieren
APA
Thaler, S., Zorn, A., Aster, I., Koliogiannis, D., Renz, B. W., Guba, M., & Groene, P. (2025). Hyperfibrinolysis Detection During Liver Transplantation Using Viscoelastometry. Clinical Transplantation. https://doi.org/10.1111/ctr.70179
Vancouver
Thaler S, Zorn A, Aster I, Koliogiannis D, Renz BW, Guba M, et al. Hyperfibrinolysis Detection During Liver Transplantation Using Viscoelastometry. Clinical Transplantation. 2025. doi:10.1111/ctr.70179
BibTeX
@article{Thaler2025,
author = {Thaler, Sarah and Zorn, Anna and Aster, Isabell and Koliogiannis, Dionysios and Renz, Bernhard W and Guba, Markus and Groene, Philipp},
title = {Hyperfibrinolysis Detection During Liver Transplantation Using Viscoelastometry},
journal = {Clinical Transplantation},
year = {2025},
doi = {10.1111/ctr.70179}
}
EUVIMED